Related references
Note: Only part of the references are listed.Defibrotide: real-world management of veno-occlusive disease/sinusoidal obstructive syndrome after stem cell transplant
Mary Nauffal et al.
BLOOD ADVANCES (2022)
A Systematic Review and Meta-Analysis of Studies of Defibrotide Prophylaxis for Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome
Selim Corbacioglu et al.
CLINICAL DRUG INVESTIGATION (2022)
The importance of endothelial protection: the emerging role of defibrotide in reversing endothelial injury and its sequelae
Paul G. Richardson et al.
BONE MARROW TRANSPLANTATION (2021)
Endothelial cell function and endothelial-related disorders following haematopoietic cell transplantation
Gerhard C. Hildebrandt et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation
Francesca Bonifazi et al.
FRONTIERS IN IMMUNOLOGY (2020)
A Meta-Analysis Evaluating the Incidence of Bleeding Events With Intravenous Defibrotide Treatment Outside the Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Setting
William Tappe et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2020)
Hepatic veno-occlusive disease following sirolimus-based immune suppression
Farhad Khimani et al.
BONE MARROW TRANSPLANTATION (2019)
Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children: a retrospective study of the Italian Hematology-Oncology Association - Hematopoietic Stem Cell Transplantation Group
Maura Faraci et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Risk Factors for Development of and Progression of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome
Selim Corbacioglu et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant
Christopher Strouse et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
The use of defibrotide in blood and marrow transplantation
Paul G. Richardson et al.
BLOOD ADVANCES (2018)
Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT)
M. Mohty et al.
BONE MARROW TRANSPLANTATION (2015)
Drug safety evaluation of defibrotide
Paul G. Richardson et al.
EXPERT OPINION ON DRUG SAFETY (2013)
Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial
Selim Corbacioglu et al.
LANCET (2012)
Hepatic Veno-Occlusive Disease following Stem Cell Transplantation: Incidence, Clinical Course, and Outcome
Jason A. Coppell et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease and Multiorgan Failure after Stem Cell Transplantation: A Multicenter, Randomized, Dose-Finding Trial
Paul G. Richardson et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children
Amrana Qureshi et al.
PEDIATRIC BLOOD & CANCER (2008)
Share Paper
